Peter Michael Vestlev
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Viral-associated cancers and disorders
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 11
- HER2/EGFR in Cancer Research 6
- Cancer Treatment and Pharmacology 3
- Bone health and treatments 2
- Cancer Diagnosis and Treatment 2
- Colorectal Cancer Treatments and Studies 2
-
- Breast Cancer Treatment Studies 4
- Cancer Genomics and Diagnostics 2
- Co-authors
- Gorm Pallesen (1 shared paper)Stephen Jacques Hamilton-Dutoit (1 shared paper)Kristian Sandvej (1 shared paper)H.T. Mouridsen (1 shared paper)Jaap Verweij (1 shared paper)Richard J Sylvester (1 shared paper)William P. Steward (1 shared paper)Andres M. Poveda (1 shared paper)
In The Last Decade
Peter Michael Vestlev
13 papers receiving 757 citations
Peter Michael Vestlev's Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 482
- Cancer Research 219
- Pulmonary and Respiratory Medicine 255
- Radiology, Nuclear Medicine and Imaging 98
- Pathology and Forensic Medicine 75
Countries citing papers authored by Peter Michael Vestlev
This map shows the geographic impact of Peter Michael Vestlev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Michael Vestlev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Michael Vestlev more than expected).
Fields of papers citing papers by Peter Michael Vestlev
This network shows the impact of papers produced by Peter Michael Vestlev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Michael Vestlev. The network helps show where Peter Michael Vestlev may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Michael Vestlev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 461 |
| 2 | 1991 | 94 | |
| 3 | 2017 | 87 | |
| 4 | 2017 | 54 | |
| 5 | 1992 | 53 | |
| 6 | 2020 | 10 | |
| 7 | 2020 | 7 | |
| 8 | 1992 | 3 | |
| 9 | 2022 | 3 | |
| 10 | Forebyggelse af skeletrelaterede hændelser hos patienter med knoglemetastaser ved solide tumorer | 2014 | 2 |
| 11 | 1990 | 1 | |
| 12 | [Prevention of skeletal related events in patients with bone metastases from solid tumours]. | 2014 | 1 |
| 13 | 2022 | 1 | |
| 14 | 2015 | 0 | |
| 15 | 2025 | 0 |
About Peter Michael Vestlev
Peter Michael Vestlev is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Hepatology and Pharmacology, having authored 15 papers that have together received 777 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Breast Cancer Treatment Studies (4 papers), Cancer Treatment and Pharmacology (3 papers), Cancer Genomics and Diagnostics (2 papers), Lung Cancer Treatments and Mutations (2 papers), Bone health and treatments (2 papers), Cancer Diagnosis and Treatment (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (482 citations), Cancer Research (219 citations), Pulmonary and Respiratory Medicine (255 citations), Radiology, Nuclear Medicine and Imaging (98 citations) and Pathology and Forensic Medicine (75 citations). Peter Michael Vestlev has collaborated with scholars based in Denmark, Spain and Australia. Frequent co-authors include Gorm Pallesen, Stephen Jacques Hamilton-Dutoit, Kristian Sandvej, H.T. Mouridsen, Jaap Verweij, Richard J Sylvester, William P. Steward, Andres M. Poveda, Denis Thomas and A.T. van Oosterom. Their work appears in journals such as Acta Oncologica, The Lancet Oncology, Journal of Clinical Oncology, Basic & Clinical Pharmacology & Toxicology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.